These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 2010 pertussis outbreak and updated Tdap recommendations. Bell GC; Foster SL J Am Pharm Assoc (2003); 2011; 51(1):118-20. PubMed ID: 21247837 [No Abstract] [Full Text] [Related]
4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763 [TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
7. Missed opportunities for adolescent vaccination, 2006-2011. Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613 [TBL] [Abstract][Full Text] [Related]
8. Research aims to boost pertussis control. Friedrich MJ JAMA; 2011 Jul; 306(1):27-9. PubMed ID: 21730232 [No Abstract] [Full Text] [Related]
9. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. Meites E; Kempe A; Markowitz LE MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(49):1405-1408. PubMed ID: 27977643 [TBL] [Abstract][Full Text] [Related]
12. Update on Adolescent Immunizations. Schreier R; Halady T; Bishop N; Chatterjee A S D Med; 2016 Feb; 69(2):78-83. PubMed ID: 26999915 [TBL] [Abstract][Full Text] [Related]
13. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age. Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980 [TBL] [Abstract][Full Text] [Related]
14. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116 [TBL] [Abstract][Full Text] [Related]
15. New recommendations for immunization against pertussis and hepatitis B. Med Lett Drugs Ther; 1992 Jul; 34(875):69-71. PubMed ID: 1385851 [No Abstract] [Full Text] [Related]
16. Update: Vaccines for women, adolescence through adulthood. Akinsanya-Beysolow I; Wolfe CS J Womens Health (Larchmt); 2009 Aug; 18(8):1101-8. PubMed ID: 19627241 [TBL] [Abstract][Full Text] [Related]
18. In brief: New adult immunization recommendations. Med Lett Drugs Ther; 2017 Apr; 59(1519):70. PubMed ID: 28419075 [No Abstract] [Full Text] [Related]
19. HPV vaccine is safe and effective and is now routinely recommended for preteen girls and boys. Michigan Department of Community Health Mich Med; 2012; 111(2):24-6. PubMed ID: 22594161 [No Abstract] [Full Text] [Related]
20. Immunization update: pertussis, meningoccocus, and human papillomavirus. Middleman AB Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]